Cell mediated and humoral immune response to acute leukemia cells and soluble leukemia antigen

relationship to immunocompetence and prognosis

J. U. Gutterman, Evan M Hersh, G. M. Mavligit, E. J. Freireich, R. D. Rossen, W. T. Butler, K. B. McCredie, G. P. Bodey, V. Rodriguez

Research output: Chapter in Book/Report/Conference proceedingChapter

20 Citations (Scopus)

Abstract

Concurrent studies of lymphocyte blastogenic response to autologous leukemia cells, of general immunocompetence, and direct membrane immunofluorescence with anti immunoglobulin serum were carried out in 35 adults with acute leukemia. In addition, lymphocyte blastogenic response of autologous and allogeneic lymphocytes to soluble leukemia antigen was studied. Of 35 patients, 25 (72%) had positive blastogenic response to their own leukemia cells. Patients with acute myelogenous leukemia (AML) tended to have a greater blastogenic response to their leukemia cells than patients with acute lymphoblastic leukemia (ALL). Eight of nineteen patients with AML and one of the five with ALL had complete or partial abrogation of this positive blastogenesis when the lymphocytes were cultured in autologous serum rather than allogeneic serum. Direct membrane immunofluorescence with anti immunoglobulin serum showed bound IgG on the cells of 7 of 8 AML patients with the serum inhibitory effect and 1 AML patient without the serum inhibitory effect. There was facilitation of blastogenic response in autologous serum compared to allogeneic serum in 5 instances. A good prognosis was correlated with a vigorous blastogenic response, its inhibition or facilitation by autologous serum, and IgG bound to the cell surface. Of 7 patients, 6 had positive blastogenic response to autologous soluble antigen. Of these 6 patients, 5 also responded to autologous leukemia cells. Although allogeneic normal donor lymphocytes responded vigorously to leukemia cells in 6 of 7 instances, only 1 of 7 allogeneic lymphocytes responded to soluble antigen. Thus, presensitization apparently is required for in vitro blastogenic response to soluble leukemia antigen.

Original languageEnglish (US)
Title of host publicationNational Cancer Institute Monograph
Pages153-165
Number of pages13
Volume37
StatePublished - 1973
Externally publishedYes

Fingerprint

Immunocompetence
Humoral Immunity
Leukemia
Antigens
Serum
Lymphocytes
Acute Myeloid Leukemia
Direct Fluorescent Antibody Technique
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Immunoglobulins
Immunoglobulin G
Membranes
Autoantigens
Lymphocyte Activation
Cohort Studies
Tissue Donors

ASJC Scopus subject areas

  • Cancer Research

Cite this

Gutterman, J. U., Hersh, E. M., Mavligit, G. M., Freireich, E. J., Rossen, R. D., Butler, W. T., ... Rodriguez, V. (1973). Cell mediated and humoral immune response to acute leukemia cells and soluble leukemia antigen: relationship to immunocompetence and prognosis. In National Cancer Institute Monograph (Vol. 37, pp. 153-165)

Cell mediated and humoral immune response to acute leukemia cells and soluble leukemia antigen : relationship to immunocompetence and prognosis. / Gutterman, J. U.; Hersh, Evan M; Mavligit, G. M.; Freireich, E. J.; Rossen, R. D.; Butler, W. T.; McCredie, K. B.; Bodey, G. P.; Rodriguez, V.

National Cancer Institute Monograph. Vol. 37 1973. p. 153-165.

Research output: Chapter in Book/Report/Conference proceedingChapter

Gutterman, JU, Hersh, EM, Mavligit, GM, Freireich, EJ, Rossen, RD, Butler, WT, McCredie, KB, Bodey, GP & Rodriguez, V 1973, Cell mediated and humoral immune response to acute leukemia cells and soluble leukemia antigen: relationship to immunocompetence and prognosis. in National Cancer Institute Monograph. vol. 37, pp. 153-165.
Gutterman JU, Hersh EM, Mavligit GM, Freireich EJ, Rossen RD, Butler WT et al. Cell mediated and humoral immune response to acute leukemia cells and soluble leukemia antigen: relationship to immunocompetence and prognosis. In National Cancer Institute Monograph. Vol. 37. 1973. p. 153-165
Gutterman, J. U. ; Hersh, Evan M ; Mavligit, G. M. ; Freireich, E. J. ; Rossen, R. D. ; Butler, W. T. ; McCredie, K. B. ; Bodey, G. P. ; Rodriguez, V. / Cell mediated and humoral immune response to acute leukemia cells and soluble leukemia antigen : relationship to immunocompetence and prognosis. National Cancer Institute Monograph. Vol. 37 1973. pp. 153-165
@inbook{d1d0a249c4e34c86b895d42d81c5926b,
title = "Cell mediated and humoral immune response to acute leukemia cells and soluble leukemia antigen: relationship to immunocompetence and prognosis",
abstract = "Concurrent studies of lymphocyte blastogenic response to autologous leukemia cells, of general immunocompetence, and direct membrane immunofluorescence with anti immunoglobulin serum were carried out in 35 adults with acute leukemia. In addition, lymphocyte blastogenic response of autologous and allogeneic lymphocytes to soluble leukemia antigen was studied. Of 35 patients, 25 (72{\%}) had positive blastogenic response to their own leukemia cells. Patients with acute myelogenous leukemia (AML) tended to have a greater blastogenic response to their leukemia cells than patients with acute lymphoblastic leukemia (ALL). Eight of nineteen patients with AML and one of the five with ALL had complete or partial abrogation of this positive blastogenesis when the lymphocytes were cultured in autologous serum rather than allogeneic serum. Direct membrane immunofluorescence with anti immunoglobulin serum showed bound IgG on the cells of 7 of 8 AML patients with the serum inhibitory effect and 1 AML patient without the serum inhibitory effect. There was facilitation of blastogenic response in autologous serum compared to allogeneic serum in 5 instances. A good prognosis was correlated with a vigorous blastogenic response, its inhibition or facilitation by autologous serum, and IgG bound to the cell surface. Of 7 patients, 6 had positive blastogenic response to autologous soluble antigen. Of these 6 patients, 5 also responded to autologous leukemia cells. Although allogeneic normal donor lymphocytes responded vigorously to leukemia cells in 6 of 7 instances, only 1 of 7 allogeneic lymphocytes responded to soluble antigen. Thus, presensitization apparently is required for in vitro blastogenic response to soluble leukemia antigen.",
author = "Gutterman, {J. U.} and Hersh, {Evan M} and Mavligit, {G. M.} and Freireich, {E. J.} and Rossen, {R. D.} and Butler, {W. T.} and McCredie, {K. B.} and Bodey, {G. P.} and V. Rodriguez",
year = "1973",
language = "English (US)",
volume = "37",
pages = "153--165",
booktitle = "National Cancer Institute Monograph",

}

TY - CHAP

T1 - Cell mediated and humoral immune response to acute leukemia cells and soluble leukemia antigen

T2 - relationship to immunocompetence and prognosis

AU - Gutterman, J. U.

AU - Hersh, Evan M

AU - Mavligit, G. M.

AU - Freireich, E. J.

AU - Rossen, R. D.

AU - Butler, W. T.

AU - McCredie, K. B.

AU - Bodey, G. P.

AU - Rodriguez, V.

PY - 1973

Y1 - 1973

N2 - Concurrent studies of lymphocyte blastogenic response to autologous leukemia cells, of general immunocompetence, and direct membrane immunofluorescence with anti immunoglobulin serum were carried out in 35 adults with acute leukemia. In addition, lymphocyte blastogenic response of autologous and allogeneic lymphocytes to soluble leukemia antigen was studied. Of 35 patients, 25 (72%) had positive blastogenic response to their own leukemia cells. Patients with acute myelogenous leukemia (AML) tended to have a greater blastogenic response to their leukemia cells than patients with acute lymphoblastic leukemia (ALL). Eight of nineteen patients with AML and one of the five with ALL had complete or partial abrogation of this positive blastogenesis when the lymphocytes were cultured in autologous serum rather than allogeneic serum. Direct membrane immunofluorescence with anti immunoglobulin serum showed bound IgG on the cells of 7 of 8 AML patients with the serum inhibitory effect and 1 AML patient without the serum inhibitory effect. There was facilitation of blastogenic response in autologous serum compared to allogeneic serum in 5 instances. A good prognosis was correlated with a vigorous blastogenic response, its inhibition or facilitation by autologous serum, and IgG bound to the cell surface. Of 7 patients, 6 had positive blastogenic response to autologous soluble antigen. Of these 6 patients, 5 also responded to autologous leukemia cells. Although allogeneic normal donor lymphocytes responded vigorously to leukemia cells in 6 of 7 instances, only 1 of 7 allogeneic lymphocytes responded to soluble antigen. Thus, presensitization apparently is required for in vitro blastogenic response to soluble leukemia antigen.

AB - Concurrent studies of lymphocyte blastogenic response to autologous leukemia cells, of general immunocompetence, and direct membrane immunofluorescence with anti immunoglobulin serum were carried out in 35 adults with acute leukemia. In addition, lymphocyte blastogenic response of autologous and allogeneic lymphocytes to soluble leukemia antigen was studied. Of 35 patients, 25 (72%) had positive blastogenic response to their own leukemia cells. Patients with acute myelogenous leukemia (AML) tended to have a greater blastogenic response to their leukemia cells than patients with acute lymphoblastic leukemia (ALL). Eight of nineteen patients with AML and one of the five with ALL had complete or partial abrogation of this positive blastogenesis when the lymphocytes were cultured in autologous serum rather than allogeneic serum. Direct membrane immunofluorescence with anti immunoglobulin serum showed bound IgG on the cells of 7 of 8 AML patients with the serum inhibitory effect and 1 AML patient without the serum inhibitory effect. There was facilitation of blastogenic response in autologous serum compared to allogeneic serum in 5 instances. A good prognosis was correlated with a vigorous blastogenic response, its inhibition or facilitation by autologous serum, and IgG bound to the cell surface. Of 7 patients, 6 had positive blastogenic response to autologous soluble antigen. Of these 6 patients, 5 also responded to autologous leukemia cells. Although allogeneic normal donor lymphocytes responded vigorously to leukemia cells in 6 of 7 instances, only 1 of 7 allogeneic lymphocytes responded to soluble antigen. Thus, presensitization apparently is required for in vitro blastogenic response to soluble leukemia antigen.

UR - http://www.scopus.com/inward/record.url?scp=0015790156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015790156&partnerID=8YFLogxK

M3 - Chapter

VL - 37

SP - 153

EP - 165

BT - National Cancer Institute Monograph

ER -